20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Ref.: C.L.57.2020
The Director-General of the World Health Organization has the honour to communicate to
Members of the Organization, in accordance with Rules 5 and 8 of the Rules of Procedure of the
... Executive Board, the provisional agenda and provisional annotated agenda for the 148th session
of the Executive Board, which will be held from Monday, 18 to Tuesday, 26 January 2021,1
commencing at 10:00 (CET).
The Executive Board decided through a written procedure that the 148th session of the
Executive Board should be organized using a virtual format, while retaining the option of
revisiting this decision and considering the use of a hybrid format if the epidemiological
situation evolved positively in the intervening period. Details for accessing the virtual platform
will be provided following completion of the registration process. Deadline for registration is
4 January 2021.
Registration can be initiated as of 14 December 2020 by going to the following link:
https://extranet.who.int/bpmext/meetingregistration.aspx., using the following username: ebuser,
and password: W%i@be=fe%450CD12187. Instructions for online registration are available for
downloading from the Governance website
(http://www.who.int/governance/registration/en/index.html).
In accordance with resolution WHA49.9 (May 1996), and to support the aim of
achievement of SDG 5 (Achieve gender equality and empower all women and girls), the
Director-General invites Member States to consider that gender balance be applied to their
delegations.
Documents for the 148th session of the Executive Board can be accessed on the Internet
... through the WHO website (http://www.who.int/gb/) as they become available and practical
information for delegates is attached.
The Director-General of the World Health Organization takes this opportunity to renew to
Members of the Organization the assurance of his highest consideration.
GENEVA, 14 December 2020
1
See Executive Board decision EB147(6), 22 May 2020.
... ENCL.: (3)
REGISTRATION
Online registration is required for both the Executive Board and the World Health Assembly.
Registration can be initiated as of 14 December 2020 by going to the following link:
https://extranet.who.int/bpmext/meetingregistration.aspx., using the following username: ebuser, and
password: W%i@be=fe%450CD12187.
Before each meeting, an invitation will be sent to Member States indicating a link to access the electronic
Governing Bodies Meeting Registration System in order to register one Focal Point at the Permanent Mission
in Geneva, who will be responsible for registering the delegation. Member States without a Permanent Mission
in Geneva should designate a Focal Point in the capital. The same process will apply to all categories of invited
participants (the United Nations, Observers, Intergovernmental Organizations and non-State actors in official
relations with WHO).
Once a Focal Point has been entered into the registration system, he/she will receive by email a unique
username and password, and the link to access the registration system.
The Focal Point will register and submit the names and titles of the delegates and attach a note verbale
containing the composition of the delegation.
The WHO Office of Governing Bodies will verify the information received from the Focal Point, which
will then be submitted into the registration system to generate the List of Participants and send the log in details
to access the virtual meeting.
CREDENTIALS
The credentials shall be issued by the Head of State, the Head of Government, the Minister for Foreign
Affairs, the Minister of Health, or any other appropriate authority, i.e. Permanent Missions and senior
government officials, such as Directors-General for Health. A copy of the credentials will have to be uploaded
and submitted through the online registration system before the opening of the 148th session of the
Executive Board. Credentials should include the following information for each participant: LAST NAME
(in capital letters), first name, title, function, institution, city, gender (unless indicated in title).
EXECUTIVE BOARD EB148/1
148th session 14 December 2020
Geneva, 18–26 January 2021
Provisional agenda
1. Opening of the session and adoption of the agenda
Documents EB148/1, EB148/1 (annotated) and EB148/2
2. Report by the Director-General
Document EB148/3
3. Report of the regional committees to the Executive Board
Document EB148/4
4. Report of the Programme, Budget and Administration Committee of the Executive Board
Document EB148/5
Pillar 1: One billion more people benefitting from universal health coverage
5. Global action on patient safety
Document EB148/6
6. Political declaration of the third high-level meeting of the General Assembly on the
prevention and control of non-communicable diseases
Documents EB148/7, EB148/7 Add.1 and EB148/7 Add.2
• Oral health
Document EB148/8
7. Expanding access to effective treatments for cancer and rare and orphan diseases, including
medicines, vaccines, medical devices, diagnostics, assistive products, cell- and gene-based
therapies and other health technologies; and improving the transparency of markets for
medicines, vaccines, and other health products
Document EB148/9
8. Global strategy and plan of action on public health, innovation and intellectual property
Document EB148/10
EB148/1
9. Antimicrobial resistance
Document EB148/11
10. Substandard and falsified medical products
Document EB148/12
11. Standardization of medical devices nomenclature
Document EB148/13
12. Immunization Agenda 2030
Document EB148/14
13. Integrated people-centred eye care, including preventable vision impairment and blindness
Document EB148/15
Pillar 2: One billion more people better protected from health emergencies
14. Public health emergencies: preparedness and response
14.1 COVID-19 response
Document EB148/16
14.2 WHO’s work in health emergencies
Document EB148/17
• Strengthening WHO’s global emergency preparedness and response
Document EB148/18
• Strengthening preparedness for health emergencies: implementation of the International
Health Regulations (2005)
Document EB148/19
14.3 Mental health preparedness and response for the COVID-19 pandemic
Document EB148/20
14.4 The public health implications of implementation of the Nagoya Protocol
Document EB148/21
2
EB148/1
15. Poliomyelitis
15.1 Poliomyelitis eradication
Document EB148/22
15.2 Polio transition planning and polio post-certification
Document EB148/23
Pillar 3: One billion more people enjoying better health and well-being
16. Social determinants of health
Document EB148/24
Pillar 4: More effective and efficient WHO providing better support to countries
17. Budget and finance matters
17.1 Proposed programme budget 2022–2023
Documents EB148/25 and EB148/25 Add.1
• Sustainable financing
Document EB148/26
17.2 Update on the financing and implementation of the Programme budget 2020–2021
Document EB148/27
17.3 Scale of assessments 2022–2023
Document EB148/28
17.4 Status of collection of assessed contributions, including Member States in arrears in the
payment of their contributions to an extent that would justify invoking Article 7 of the
Constitution
Document EB148/29
17.5 Amendments to the Financial Regulations and Financial Rules [if any]
18. Update on the Infrastructure Fund
18.1 Update on information management and technology
Document EB148/30
3
EB148/1
18.2 Geneva buildings renovation strategy
Document EB148/31
19. Governance matters
19.1 WHO transformation
Document EB148/32
19.2 WHO reform
• WHO reform: governance
Document EB148/33
• WHO reform: World health days
Document EB148/34
• WHO reform: involvement of non-State actors in WHO’s governing bodies
Document EB148/35
19.3 Global strategies and plans of action that are scheduled to expire within one year
• WHO global disability action plan 2014–2021: better health for all people with disability
Document EB148/36
• The global health sector strategies on, respectively, HIV, viral hepatitis and sexually
transmitted infections, for the period 2016–2021
Document EB148/37
19.4 Process for the election of the Director-General of the World Health Organization
Document EB148/38
19.5 Engagement with non-State actors
• Report on the implementation of the Framework of Engagement with Non-State Actors
Document EB148/39
• Non-State actors in official relations with WHO
Document EB148/40
4
EB148/1
19.6 Provisional agenda of the Seventy-fourth World Health Assembly and date and place of
the 149th session of the Executive Board
Documents EB148/41 and EB148/42
20. Committees of the Executive Board
20.1 Foundation committees and selection panels
Document EB148/43
21. Staffing matters
21.1 Statement by the representative of the WHO staff associations
Document EB148/INF./1
21.2 Report of the Ombudsman
Documents EB148/INF./2 and EB148/INF./3
21.3 Human resources: update
Document EB148/44
21.4 Amendments to the Staff Regulations and Staff Rules
Document EB148/45
21.5 Report of the International Civil Service Commission
Document EB148/46
22. Report on meetings of expert committees and study groups
• Expert advisory panels and committees and their membership
Documents EB148/47 and EB148/47 Add.1
23. Closure of the session
= = =
5
EXECUTIVE BOARD EB148/1 (annotated)
148th session 14 December 2020
Geneva, 18–26 January 2021
Provisional agenda (annotated)
1. Opening of the session and adoption of the agenda
During the opening of the session, Members of the Executive Board will be invited to also consider the adoption
of special procedures to regulate the conduct of the virtual sessions of the Executive Board allowing it to pursue
its work in a virtual format.
2. Report by the Director-General
3. Report of the regional committees to the Executive Board
In decision WHA65(9) (2012), the Health Assembly endorsed the proposal that the chairpersons of the regional
committees routinely submit to the Board summary reports of the committees’ deliberations. The Board will be
invited to consider the recommendations and comments of the regional committees.
4. Report of the Programme, Budget and Administration Committee of the Executive Board
The Board will receive at the opening of its session the report of the thirty-third meeting of the Programme, Budget
and Administration Committee, which is scheduled to be held from 13 to 15 January 2021.
Pillar 1: One billion more people benefitting from universal health coverage
5. Global action on patient safety
Patient safety is a growing global challenge and is a prerequisite for strengthening health care systems and making
progress towards effective universal health coverage under Sustainable Development Goal 3. In response to the
request in resolution WHA72.6 (2019), the Director-General will submit a draft global patient safety action plan.
The report will outline the purpose, vision, guiding principles, framework for action with strategic objectives, and
the global patient safety targets. The Board will be invited to consider a draft decision recommending that the
Seventy-fourth World Health Assembly endorse the global action plan.
6. Political declaration of the third high-level meeting of the General Assembly on the
prevention and control of non-communicable diseases
A report will be submitted in response to the request in decision WHA72(11) (2019) to the Director-General “to
consolidate reporting on the progress achieved in the prevention and control of noncommunicable diseases and the
promotion of mental health with an annual report …, annexing reports on implementation of relevant resolutions,
action plans and strategies, in line with existing reporting mandates and timelines”. The report will also include
the biennial report on the implementation of the commitments made in the Rome Declaration on Nutrition, adopted
at the Second International Conference on Nutrition (2014). The Board will be invited to note the report and its
annexes, adopt the proposed updates to the appendices of WHO’s comprehensive mental health action plan
2013–2030, and provide guidance on the continued relevance of WHO’s global action plan for the prevention and
control of noncommunicable diseases 2013–2020 and the global coordination mechanism on the prevention and
EB148/1 (annotated)
control of noncommunicable diseases. In this exercise, the Board will be able to take into account the outcomes of
two evaluations, the executive summaries of which will be submitted by the Evaluation Office in separate reports.
• Oral health
At the recommendation of the Officers of the Executive Board, the Director-General will submit a report outlining
the challenges to global public health posed by oral diseases, recent oral health activities of the Secretariat, and
actions towards better oral health by 2030 as part of the work on noncommunicable diseases and universal health
coverage. The Board will be invited to note the report and provide guidance on the way forward.
7. Expanding access to effective treatments for cancer and rare and orphan diseases, including
medicines, vaccines, medical devices, diagnostics, assistive products, cell- and gene-based
therapies and other health technologies; and improving the transparency of markets for
medicines, vaccines and other health products
At the recommendation of the Officers of the Executive Board in 2019,1 and pursuant to resolutions
WHA70.12 (2017) and WHA72.8 (2019), the Director-General will submit a report on progress that includes
access to health products for rare and orphan diseases. The Board will be invited to note the progress made and to
provide further guidance on optimizing access to cell- and gene-based therapeutics and other health products for
rare and orphan diseases.
8. Global strategy and plan of action on public health, innovation and intellectual property
In response to the request in decision WHA73(11) (2020), the Director-General will submit a report on progress
made in implementing the decision, including an update on the informal consultations referred to in paragraphs
(2) and (3) of the decision. The Board will be invited to note the report.
9. Antimicrobial resistance
Pursuant to resolution WHA72.5 (2019), the Director-General will submit a report that: outlines progress in
implementing the global action plan on antimicrobial resistance; provides an update on activities towards achieving
the five strategic objectives of the global action plan, on progress in global coordination and tripartite partnership
efforts; and highlights the main country-level and global challenges in programme implementation. The Board
will be invited to note the report and provide guidance on accelerating Member States’ implementation of national
action plans on antimicrobial resistance and on enhancing feedback from health ministries on the process to review
the Codex Code of Practice to Minimize and Contain Foodborne Antimicrobial Resistance.
10. Substandard and falsified medical products
Pursuant to resolution WHA65.19 (2012) a report based on the outcomes of the eighth and ninth plenary meetings
of the Member State mechanism on substandard and falsified medical products will be submitted to the
Seventy-fourth World Health Assembly through the Board. It will include a review of the progress made in
implementing the workplan (list of prioritized activities) for the period of 2020–2021. The Board will also receive
information on the one-year extension of the current composition of the Steering Committee in order to align the
term of office of the Steering Committee with the timespan of the workplan.
1 See Note for the Record of the meeting of the Director-General and the Officers of the Executive Board on 5 and
6 October 2019 (https://apps.who.int/gb/gov/assets/NFR_5-6-10-2019_en.pdf, accessed 14 December 2020).
2
EB148/1 (annotated)
11. Standardization of medical devices nomenclature
As agreed by the Board at its 145th session,1 the Director-General will submit a report on further work undertaken
and the outcome of consultations. It will include an analysis of existing systems and confirmation that WHO will
neither develop a new nomenclature of medical devices nor adopt a proprietary system but will harmonize with
the European Medical Device Nomenclature, which will support regulation, assessment and management of
medical devices to improve access. The Board will be invited to note the progress made and provide further
guidance, for instance on the next steps.
12. Immunization Agenda 2030
Following the request in decision WHA73(9) (2020), the Director-General will submit a report on the finalization
of the operational elements outlined in the Immunization Agenda 2030. The Board will be invited to note the report
and to provide guidance on the proposed frameworks for ownership and accountability and for monitoring and
evaluation.
13. Integrated people-centred eye care, including preventable vision impairment and blindness
Pursuant to resolution WHA73.4 (2020), the Director-General will submit a report with recommendations for
feasible global targets for 2030 on effective coverage of both treatment of refractive error and cataract surgery, for
consideration by the Seventy-fourth World Health Assembly. The Board will be invited to note the report and
provide further guidance.
Pillar 2: One billion more people better protected from health emergencies
14. Public health emergencies: preparedness and response
14.1 COVID-19 response
Further to the document submitted to the Executive Board at its fifth special session (on the COVID-19 response),2
the Director-General will submit a report to provide the Board with an update on the Secretariat’s activities to
combat the pandemic of coronavirus (COVID-19).
14.2 WHO’s work in health emergencies
Pursuant to requests in resolution EBSS3.R1 (2015), decision WHA68(10) (2015) and resolution WHA73.8
(2020), the Director-General will submit a report which will: provide updates on all public health emergencies of
international concern, Grade 3 and United Nations Inter-Agency Standing Committee Level 3 emergencies in
which WHO took action in 2020 (up to August) and on the progress made to improve research and development
for potentially epidemic diseases; and describe the work WHO is undertaking at global, regional and country levels
in order to prepare for, prevent, detect and respond to health emergencies, including its role as health cluster lead.
The Board will be invited to note the report.
• Strengthening WHO’s global emergency preparedness and response
At the recommendation of the Officers of the Executive Board, the Director-General will submit a report on
strengthening WHO’s global emergency preparedness and response. It is intended that the report will support a
discussion on the opportunities for making progress on strengthening the capacity of the WHO Secretariat and
Member States to fulfil their respective roles in preventing, detecting and responding to health emergencies,
1 Document EB145/2019/REC/1, summary record of the first meeting, section 5.
2 Document EBSS/5/2.
3
EB148/1 (annotated)
including outbreaks, in order to protect and improve global public health by full implementation of the
International Health Regulations (2005).
• Strengthening preparedness for health emergencies: implementation of the International
Health Regulations (2005)
Pursuant to requests made by the Health Assembly in resolutions WHA73.1 (2020) and WHA73.8, on September
2020 the Director-General convened the Review Committee on the functioning of the International Health
Regulations (2005) during the COVID-19 response. The Director-General will transmit the Review Committee’s
interim progress report to the Executive Board for its consideration.
14.3 Mental health preparedness and response for the COVID-19 pandemic
At the recommendation of the Officers of the Executive Board, the Director-General will submit a report on
addressing the mental health dimension of the COVID-19 pandemic, including the essential place that mental
health should have in all preparedness actions and responses to COVID-19, and on ensuring that mental health is
included in universal health coverage as countries recover from the pandemic. The Board will be invited to note
the report and provide further guidance.
14.4 The public health implications of implementation of the Nagoya Protocol
Pursuant to decision WHA72(13) (2019), the Director-General will submit a report on current pathogen-sharing
practices and arrangements, the implementation of access and benefit-sharing measures, and the potential public
health outcomes and other implications of implementation of the Nagoya Protocol. The Board will be invited to
note the report and consider recommending that the Health Assembly request the Secretariat to continue its work
in this area.
15. Poliomyelitis
15.1 Poliomyelitis eradication
In line with the request in resolution WHA61.1 (2008), the Director-General will submit an update on: efforts to
interrupt remaining wild poliovirus transmission; the responses to outbreaks due to circulating vaccine-derived
poliovirus type 2 and the introduction of novel oral polio vaccine type 2; the impact of COVID-19 on the polio
eradication programme; a review of the governance of the Global Polio Eradication Initiative and the process for
developing a new strategy; and the financing situation at end-2020. The Board will be invited to note the report.
15.2 Polio transition planning and polio post-certification
Pursuant to decision WHA70.9 (2017), the Director-General will provide a status update on the implementation
of WHO’s Strategic Action Plan on Polio Transition for the period 2019–2023, with a focus on measures taken to
address those COVID-19 restrictions that risk impeding its implementation, as well as a summary of progress with
priority country action plans. The Board will be invited to note the report.
Pillar 3: One billion more people enjoying better health and well-being
16. Social determinants of health
At the recommendation of the Officers of the Executive Board,1 the Director-General will submit a report on
addressing social determinants of health, namely, the conditions in which people grow, learn, live, work and age
1 See document EB146/1 (annotated).
4
EB148/1 (annotated)
that have negative consequences on many health outcomes and on health equity, as illustrated by COVID-19. The
Board will be invited to note the report and provide further guidance.
Pillar 4: More effective and efficient WHO providing better support to countries
17. Budget and finance matters
17.1 Proposed programme budget 2022–2023
Using input provided by the regional committees, the draft Proposed programme budget 2022–2023 will
be submitted for consideration by the Board. In response to requests made at recent meetings of the
governing bodies, the Board will also receive information on progress towards achieving the United
Nations System-wide Action Plan on Gender Equality and the Empowerment of Women (UN-SWAP).
• Sustainable financing
In response to comments made during the discussions at the thirty-second meeting of the Programme, Budget and
Administration Committee of the Executive Board, and in Committee B of the Seventy-third World Health
Assembly (resumed), the Director-General will submit a report to enable the Board to discuss the subject of
sustainable funding.
17.2 Update on the financing and implementation of the Programme budget 2020–2021
The Director-General will submit a report on the financing and implementation of the Programme budget
2020–2021, which the Board will be invited to note.
17.3 Scale of assessments 2022–2023
The Board will be invited to consider the scale of assessments for 2022–2023, together with a draft resolution
recommending adoption of the scale by the Seventy-fourth World Health Assembly.
17.4 Status of collection of assessed contributions, including Member States in arrears in the
payment of their contributions to an extent that would justify invoking Article 7 of the
Constitution
The Director-General will submit a report on status of collection of assessed contributions, including Member
States in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the
Constitution.
17.5 Amendments to the Financial Regulations and Financial Rules [if any]
18. Update on the Infrastructure Fund
18.1 Update on information management and technology
In response to comments made during discussions of the Programme, Budget and Administration Committee of
the Executive Board at its thirty-second meeting,1 the Director-General will submit a report on the Secretariat’s
management of cybersecurity.
1 Document EB146/3.
5
EB148/1 (annotated)
18.2 Geneva buildings renovation strategy
In line with decisions WHA69(18) (2016) and WHA70(16) (2017), and as requested by the Programme, Budget
and Administration Committee of the Executive Board,1 the Director-General will submit a report to update the
Board on the status of the construction and renovation projects, and will provide details of progress made against
previously reported timelines and cost updates.
19. Governance matters
19.1 WHO transformation
In response to the recommendation made by the Programme, Budget and Administration Committee of the
Executive Board,1 with which the Executive Board had concurred at its 146th session, 2 the Director-General will
submit a report to update the Board on progress made in implementing the transformation agenda.
19.2 WHO reform
• WHO reform: governance
Further to the Board’s request in decision EB146(21) (2020), the Director-General will submit recommendations
drawn up after informal consultations with Member States on governance reform, held on 26 November 2020 and
8 December 2020. Member States considered establishing end dates for reporting on resolutions and decisions that
have unspecified reporting requirements, and consolidating and managing reporting requirements on similar
subjects. The Board will be invited to note the report and consider a draft decision.
• WHO reform: World health days
In response to comments made during the deliberations of Committee B of the Seventy-third World Health
Assembly (resumed), the Director-General will submit a report in order to enable the Board to discuss the subject
of world health days in the context of WHO reform.
• WHO reform: involvement of non-State actors in WHO’s governing bodies
In February 2020 the Executive Board at its 146th session, noted the proposals for improving involvement of
non-State actors in WHO governing bodies, and requested the Secretariat to submit a revised version of the report
to the Board at its 148th session.3 This report responds to that request, and in particular provides further information
and proposals for the informal meeting between non-State actors, WHO technical units and Member States. The
Board is invited to note the report and decide if the proposed new approach to non-State actor involvement and
the informal meeting should be tested at the Seventy-fourth World Health Assembly.
19.3 Global strategies and plans of action that are scheduled to expire within one year
• WHO global disability action plan 2014–2021: better health for all people with disability
As requested in decision WHA73(15) (2020) regarding global strategies or action plans that are scheduled to expire
within one year, the Director-General will submit a report on the WHO global disability action plan 2014–2021.
1 Document EB146/3.
2 See document EB146/2020/REC/2, summary record of the second meeting, section 3.
3 See document EB146/2020/REC/2, summary record of the fourteenth meeting, section 5.
6
EB148/1 (annotated)
It will describe the progress made in implementing resolution WHA67.7 (2014) and the lessons learned. The Board
will be invited to take note of the report and provide further guidance.
• The global health sector strategies on, respectively, HIV, viral hepatitis and sexually
transmitted infections, for the period 2016–2021
As requested in decision WHA73(15) (2020) regarding global strategies or action plans that are scheduled to expire
within one year, the Director-General will submit a report on the implementation of resolution WHA69.22 (2016)
describing progress made in tackling HIV, viral hepatitis and sexually transmitted infections, the challenges faced
in achieving the 2030 goals, and the lessons learned to date. The Board will be invited to take note of the report
and provide further guidance.
19.4 Process for the election of the Director-General of the World Health Organization
In the context of the relevant Rules of Procedure, resolutions and decisions, the Note by the Legal Counsel will
provide additional details on: the proposal of candidates, leave status of internal candidates, electoral campaign
activities at sessions of the regional committees, candidates’ forums, support for nominated candidates in the
period between the relevant sessions of the Executive Board and the Health Assembly. Additionally, the Board
will receive information on the process from an information management and technology perspective. The Board
will be invited to note the Note by the Legal Counsel and to consider requesting the Secretariat to conduct a study
on optical scanners with a view to reporting to the Seventy-fourth Health Assembly, and recommending that
nominated candidates address the Health Assembly before the vote and that financial support for travel be provided
to all candidates participating in the candidates’ forums.
19.5 Engagement with non-State actors
• Report on the implementation of the Framework of Engagement with Non-State Actors
In accordance with resolution WHA69.10 (2016) and the Framework of Engagement with Non-State Actors
(subparagraph 68(a)), the Director-General will submit the annual report on WHO’s implementation of the
Framework of Engagement with Non-State Actors, illustrating engagements with entities and reporting on the
different aspects of the implementation of the Framework at the three levels of the Organization. The Board will
be invited to note the report.
• Non-State actors in official relations with WHO
In line with the provisions of the Framework of Engagement with Non-State Actors, the Executive Board is
mandated, through its Programme, Budget and Administration Committee, to consider applications for admittance
of non-State actors into official relations and to review collaboration with one third of the non-State actors in
official relations in order to decide whether to maintain, defer the review or discontinue their official relations.
The Board will be invited to note the report and to consider a draft decision.
19.6 Provisional agenda of the Seventy-fourth World Health Assembly and date and place of
the 149th session of the Executive Board
20. Committees of the Executive Board
20.1 Foundation committees and selection panels
The Director-General will submit reports summarizing the outcomes of the meetings of the selection panels and
committees of the foundations for the prizes to be awarded in 2021, including the nominations received,
recommendations of the panels and/or committees.
7
EB148/1 (annotated)
21. Staffing matters
21.1 Statement by the representative of the WHO staff associations
21.2 Report of the Ombudsman
21.3 Human resources: update
The Director-General will provide an update on the implementation of the Organization-wide human resources
strategy and its three pillars (attracting talent, retaining talent and an enabling working environment), together with
an analysis of workforce data. In response to requests made at recent meetings of the governing bodies, and in the
context of its consideration of human resources matters, the Board will also receive information on progress
towards achieving the relevant aspects of the United Nations System-wide Action Plan on Gender Equality and
the Empowerment of Women (UN-SWAP).
21.4 Amendments to the Staff Regulations and Staff Rules
Amendments to the Staff Rules made by the Director-General will be submitted for confirmation by the Board in
accordance with Staff Regulation 12.2. Proposed amendments to the Staff Regulations will be presented for
consideration by the Board for submission to the Seventy-fourth World Health Assembly. The Board will be
invited to note the report and consider three draft resolutions.
21.5 Report of the International Civil Service Commission
The Director-General will make the Commission’s report and recommendations available to the Board. The
Secretariat will provide the Board with a verbal summary of the salient points.
22. Report on meetings of expert committees and study groups
• Expert advisory panels and committees and their membership
In compliance with Regulation 4.23 of the Regulations for Expert Advisory Panels and Committees, the
Director-General will submit a report on meetings of expert committees and study groups, including a summary
of the recommendations contained in the reports of expert committees and observations on their significance for
public health policies and implications for the Organization’s programmes. The Board will be invited to note the
report.
In addition, the Director-General will provide details of both meetings and membership in respect of expert
committees that met in 2020.
23. Closure of the session
Note:
1. At their virtual meeting with the Director-General on 16 September 2020, convened in accordance with
Rule 8 of the Rules of Procedure of the Executive Board, the Officers of the Executive Board discussed, among
other things, the draft provisional agenda that had been transmitted to Member States for comment on
19 June 2020. They considered the implications for the agenda arising from the written silence procedure, together
with a number of proposals for items to be added to the agenda, and agreed to make various recommendations.
2. The Secretariat explained that the written silence procedure, completed on 3 August 2020, had enabled
four resolutions and eight decisions to be adopted. Of those, resolution WHA73.4 (on eye care) and decision
WHA73(9) (on the Immunization Agenda 2030) requested the Director-General to take actions that were to be
8
EB148/1 (annotated)
considered by the Executive Board at its 148th session. A further decision thus adopted – WHA73(15) (on WHO
reform: governance) – requested the Director-General to “systematically include as substantive items on the
agendas of meetings of the WHO governing bodies any global strategies or action plans that are scheduled to
expire within one year in order to allow Member States to consider whether global strategies or action plans have
fulfilled their mandates, should be extended and/or need to be adjusted.” As a result, the following needed to be
considered by the Executive Board in January 2021:
• WHO global disability action plan 2014–2021: better health for all people with disability
(resolution WHA67.7) (2014). As one of the additional items, proposed by the Governments of Mexico,
Israel and New Zealand, concerned dealing with challenges faced by persons with disabilities in times
of emergency, this could be taken up on the Provisional agenda under either Pillar 1 or Pillar 4;
• The global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted
infections, for the period 2016–2021 (resolution WHA69.22) (2016).
3. After discussing the outcome of the written silence procedure and the additional agenda items proposed by
Member States, the Officers decided to recommend that the following items be included in the Provisional agenda,
on the understanding that it was realistic and feasible for the Executive Board to deal with its agenda as amended:
• following the written silence procedure:
(i) Immunization Agenda 2030, as new item 12
(ii) Integrated people-centred eye care, including preventable vision impairment and blindness,
as new item 13
(iii) the global instruments listed in paragraph 4 above, through the creation of a new item 19.3,
entitled “Global strategies and plans of action that are scheduled to expire within one year”;
• the item on oral health, proposed by the Government of Sri Lanka, which would be added as a bullet
under existing item 6;
• the item on mental health preparedness and response for the COVID-19 pandemic, proposed by the
Government of Thailand, under Pillar 2 in view of the strong links with emergency preparedness, with
the Secretariat to decide on its exact positioning within item 14;
• the item on strengthening WHO’s global emergency preparedness and response, proposed by the
Government of the United States of America, which would be added as a bullet under existing item 14.2.
4. Following an explanation from the Secretariat, the Officers also recommended that the following items be
deleted from the Provisional agenda:
• Item 12.3 on Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines
and other benefits as the Secretariat had submitted a report to be considered by the Seventy-third World
Health Assembly at its resumed session,1 in which the Secretariat explained that it had fully implemented
the recommendations of the 2016 review to develop clear, harmonized and simplified reporting on
implementation of the PIP Framework, and that all actions under resolution WHA64.5 and section 7.4.1
of the PIP Framework had been addressed;
1 Document A73/4 Add.1.
9
EB148/1 (annotated)
• Item 18.1 on Membership of the Independent Expert Oversight Advisory Committee as matters
concerning membership needed to be discussed at the 149th session of the Executive Board.
5. At a further virtual meeting with the Director-General, convened on 27 November 2020, the Officers of the
Bureau, among other things, reviewed an updated version of the draft Provisional agenda of the 148th session of
the Executive Board, which had been prepared in order to indicate changes proposed to the draft Provisional
agenda currently posted on the web. The proposed changes fell into two categories:
• changes recommended by the Bureau at its previous meeting in September (including those mandated by
resolutions and decisions adopted in August through the written silence procedure)1
• changes stemming from recommendations of the thirty-second meeting of the PBAC in October and
resolutions and decisions adopted at the resumed sessions of the Health Assembly in November.
6. The following changes were proposed, relating to mandates provided by the October and November
sessions of the governing bodies:
• following adoption of resolution WHA73.8, a second bullet point to be added under the subitem on
WHO’s work in health emergencies, entitled “Strengthening preparedness for health emergencies:
implementation of the International Health Regulations (2005)”;
• following the discussions at the thirty-second meeting of PBAC and in Committee B of the Seventy-third
World Health Assembly (resumed), a bullet point to be added under the subitem on the Proposed
programme budget 2022–2023, entitled “Sustainable financing”;
• following the adoption of decision WHA73(31), under the item on Budget and finance matters, a new
subitem 17.4 to be added, entitled “Status of collection of assessed contributions, including Member
States in arrears in the payment of their contributions to an extent that would justify invoking Article 7
of the Constitution”;
• following the PBAC’s request to the Secretariat, at its thirty-second meeting, to submit a report on
cybersecurity, the title of the item on Geneva buildings renovation strategy to be changed to read
“Update on the Infrastructure Fund”, with the old item title becoming the title of a second subitem; a
new first subitem to be added, entitled “Update on information management and technology”;
• following the discussion in Committee B of the Seventy-third World Health Assembly (resumed), under
the item on Governance matters, a bullet point to be added below the subitem on WHO reform, entitled
“WHO reform: World Health Days”.
7. United Nations System-wide Action Plan on Gender Equality and the Empowerment of Women
(UN-SWAP). In respect of requests made by PBAC and in Committee B of the Seventy-third World Health
Assembly, the Secretariat did not propose to add an item on the UN-SWAP process, as the matter could be covered
under the relevant section of the Proposed programme budget and under the subitem on the human resources
update.
8. The Officers of the Board agreed that the Provisional agenda should be finalized by making the changes
mentioned above.
= = =
1 See the Note for the Record of the meeting of the Director-General with the Officers of the Executive Board on
16 September 2020 (https://apps.who.int/gb/gov/en/chair-and-officers-of-the-executive-board_en.html).
10
Saatja: <
[email protected]>
Saadetud: 14.12.2020 19:49
Teema: WHO: C.L.57.2020 (EB148)
Dear Member States of the World Health Organization,Please find attached,
in the six official languages, C.L.57.2020 regarding the 148th session of
the Executive Board (18-26 January 2021).Best regards,Department of
Governing BodiesWorld Health Organization